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Introduction
Nasopharyngeal carcinoma (NPC) is the third most
common cancer and the third most common cause of
cancer death in the local male population. The loss of
working life due to NPC is substantial.1 The extent of
disease at diagnosis is the most important prognostic
factor2-7: patients who have stage I NPC (using Ho’s
terminology8) have a tumour that is confined to the
nasopharynx and can achieve a 5-year actuarial survival
of 81%. In contrast, the median survival for patients
who have distant metastases (stage V) is only 5
months.9
One of the significant factors associated with the
presenting stage of NPC is the duration of symptoms
before the establishment of the diagnosis. In a preceding
retrospective study,10 it was shown that the likeli-
hood of presenting with stage I-II diseases decreases
by 2% for every extra month’s delay in diagnosis. In
addition to the decreased ability of completing radical
radiotherapy, patients who have had symptoms for 6
months or longer before diagnosis have a significantly
inferior outcome when compared with those who have
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This is a descriptive study of 168 patients with nasopharyngeal carcinoma who were referred to
public clinical oncology departments for primary treatment between July and September 1996.
The mean duration from the onset of symptoms to histological diagnosis was 5.0 months; the duration
ranged from 6.1 months (for patients presenting with nasal symptoms) to 1.8 months (for those with
cranial nerve dysfunction). The mean period between the onset of symptoms and the seeking of
medical advice was 2.9 months. For 54% of the patients, there was a further delay of up to 2.4
months between the initial medical consultation and referral to the appropriate specialist. The
majority (84%) of patients attended public institutions for histological confirmation. The mean
total time taken from the onset of symptoms to the commencement of radiotherapy was 6.5 months
(range, 1.3-74.0 months)—45% of the delay was attributed to the patient, 20% to initial consultations,
14% to diagnostic arrangement, and 21% to preparation for radiotherapy. Concerted efforts are
needed to minimise further the time between the onset of symptoms and treatment. A substantial
reduction in this delay can be achieved if both public and primary care doctors were made more
aware of the significance of relevant symptoms.
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had a shorter delay in diagnosis.10 The importance of
early detection cannot be overemphasised.
During 1976 to 1980 at the Queen Elizabeth
Hospital, the mean duration of symptoms before NPC
diagnosis was as long as 8.8 months. With efforts in
public education and increasing awareness, this
time lag had decreased to 7.4 months during 1981 to
1985.10 This is still undesirably long, however, and a
further reduction is needed to minimise the delay in
presentation and diagnosis. There are currently no
published data on the exact causes of delay in diagnosis
for the NPC patients from the previous study.10 The
purpose of this survey is not only to assess the current
trends in the presentation of NPC patients, but also
to identify opportunities for further minimisation of
time lapse so that future improvements can be made
and appropriately targeted.
Subjects and methods
All patients with undifferentiated or non-keratinising
carcinoma of the nasopharynx who were referred to
the clinical oncology departments at the Queen
Elizabeth, Queen Mary, Prince of Wales, Tuen Mun,
and Pamela Youde Nethersole Eastern hospitals for
primary treatment between July and September 1996
were interviewed. The following data were collected:
(1) The main presenting symptom.
(2) The duration from the first symptom to the first
medical consultation.
(3) Whether the doctor who established the diagnosis
was the first doctor consulted.
(4) If not, the period until referral to an appropriate
specialist.
(5) The specialty and affiliation of the doctor who
established the diagnosis.
(6) Waiting time before the first appointment with a
specialist.
(7) The time taken by the specialist to attain histo-
logical confirmation of NPC and to refer the patient
to a clinical oncology department.
(8) The duration from the first appointment with a radio-
therapist to the commencement of radiotherapy.
Patients with non-epidermoid malignancy of the
nasopharynx or who had had previous treatment were
excluded from analysis, as were three patients who
failed to give a clear history of symptoms and duration.
There were 168 evaluable patients. The male to female
ratio was 2.2:1, and their ages ranged from 19 to 82
years (median, 50 years). All patients were staged by
thorough physical examination, direct fibroscopic
examination of the upper airway, computed tomography,
and chest radiography. Further metastatic work-ups
(ultrasonography of the liver and bone scanning) were
added for patients who had extensive lymphatic spread
or symptoms suggestive of NPC metastasis.
For patients without gross distant metastases, the
treatment policy was to give radical radiotherapy as far
as technically feasible. Chemotherapy (mainly a cisplatin-
containing regimen) was also given to those who had
advanced disease or a poor response to radiotherapy.
Results
Relation between presenting symptom and delay in
diagnosis
Table 1 lists the main presenting symptoms, their res-
pective frequency, and the delay in diagnosis. The most
common complaints were nasal symptoms (42.3%) and
painless neck mass (41.7%). Fifteen (8.9%) patients
presented with otological symptoms and seven (4.2%)
presented with headache. Two patients (1.2%) were
asymptomatic.
Among the symptomatic patients, the mean durat-
ion from the date of the first symptom to the date first
seen by any doctor was 2.9 months (range, 0.0-61.9
months). Forty-one (24.4%) patients had symptom(s)
for more than 6 months before presentation. Patients
with symptoms due to cranial nerve dysfunction sought
medical advice earlier than those with nasal symptoms
(0.2 versus 3.6 months). The mean duration from the
first medical consultation to the date of histological
diagnosis was 2.1 months (range, 0.0-50.7 months).
Doctors took longer to establish the diagnosis in
patients who presented with otological symptoms than
in those who had a neck mass (2.7 versus 1.2 months).
The mean duration from the date of the first symp-
tom to the date of histological diagnosis was 5.0 months
(range, <0.1-72.4 months). This varied from 1.8 months
for patients presenting with nerve palsy to 6.1 months
for those presenting with nasal symptoms (Table 1).
Time course of events leading to treatment
A detailed breakdown of the time taken for different
steps leading to diagnosis and treatment are sum-
marised in Table 2. Ninety (53.6%) patients spent a
mean interval of 2.4 months (range, <0.1-48.1 months)
consulting various doctors before being referred to a
specialist who established the diagnosis. For the whole
series, the mean interval was 1.3 months.
Only 27 (16.1%) patients had a biopsy done by
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specialists in the private sector, whereas the remainder
were referred to public institutes for histological con-
firmation. Most (n=114, 67.9%) patients were diag-
nosed by otolaryngologists at public hospitals, and only
four (2.4%) patients were referred directly to radio-
therapists for both diagnosis and treatment.
The mean interval between the date of referral to
the diagnostic specialist and the date of referral to a
clinical oncology department was 0.9 months (Tables
2 and 3). Specialists in the private sector offered a
significantly shorter waiting time for the first appoint-
ment. In addition, these specialists could arrange biopsy
and subsequent referral to clinical oncology depart-
ments more speedily. Hence, the total time taken by
the private sector was shorter than that by public
departments (0.2 versus 1.1 months) [Table 3].
The mean interval between the date of referral to
a clinical oncology department and the date of com-
mencement of radiotherapy was 1.4 months (Table 4).
This ranged from 0.9 to 1.8 months among the different
centres. While the mean waiting time for the first
appointment varied from 0.1 to 0.2 months, the mean
Table 1. Presenting symptoms and time lapse before attaining diagnosis
Presenting Patients, n=168 Median duration (range) [months]
symptom No. (%)
Patient-related* Doctor-related† Total
Nasal symptom  71 (42.3) 3.6 (0.0-61.9) 2.5 (<0.1-50.7) 6.1 (<0.1-72.4)
Neck mass  70 (41.7) 2.7 (0.0-23.3) 1.2 (0.0-15.9) 3.9 (0.2-23.5)
Otological symptom 15 (8.9) 1.9 (0.0-7.7) 2.7 (<0.1-12.0) 4.6 (0.6-19.0)
Headache 7 (4.2) 2.6 (0.0-12.0) 1.8 (0.2-6.6) 4.4 (0.7-12.7)
Nerve dysfunction 2 (1.2) 0.2 (0.1-0.2) 1.7 (0.7-2.7) 1.8 (0.8-2.9)
Other 1 (0.6) 6.0  37.5  43.5
None 2 (1.2) na 0.1 (<0.1-0.1) 0.1 (<0.1-0.1)
* Interval from first symptom to first medical consultation
†
 Interval from first medical consultation to date of histological diagnosis
na   not applicable
Table 2. Time course of events leading to treatment
Stage Interval (months)
Mean 95% range Full range
First symptom
↓ 2.9 0.0-12.8 0.0-61.9
Appointment with first doctor
↓ 1.3 0.0-10.3 0.0-48.1
Referral to diagnostic specialist
↓ 0.2 0.0-1.6 0.0-2.9
First appointment with diagnostic specialist
↓ 0.6 0.0-1.9 0.0-37.5
Histological diagnosis
↓ 0.1 -0.2*-0.6 -0.8*-0.8
Referral to radiotherapist
↓ 0.2 0.0-0.4 0.0-0.6
First appointment with radiotherapist
↓ 1.3 0.5-2.0 0.5-3.3
Commencement of radiotherapy
* Negative value because patients were referred to a radiotherapist before biopsy
Table 3. Time taken to arrange histological diagnosis and referral to a radiotherapist
Sector Patients Mean duration (range) [months]
No. (%)
Appointment* Biopsy† Referral‡ Total
Private 27 (16.1) <0.1 (0.0-<0.1) 0.1 (0.0-0.4) 0.1 (-0.1-0.2) 0.2 (0.1-0.4)
Public 141 (83.9) 0.2 (0.0-1.8) 0.7 (0.0-2.2) 0.1 (-0.9-0.6) 1.1 (0.0-3.2)
Total 168 0.2 (0.0-1.6) 0.6 (0.0-1.9) 0.1 (-0.2-0.6) 0.9 (0.0-2.7)
* Waiting time for first appointment with the diagnostic specialist
†
 Interval from the date of first appointment to biopsy
‡
 Interval from the date of biopsy to referral to a radiotherapist
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duration from the first appointment to the actual
commencement of radiotherapy ranged from 0.8 to 1.6
months.
The overall mean duration from the date of the first
symptom to the commencement of radiotherapy was
6.5 months (range, 1.3-74.0 months). In addition to
the delay in presentation, three patients took another
1.7 to 4.1 months to agree to treatment. The total
delay attributable to the symptomatic patient amounted
to 2.9 months (range, 0.0-61.9 months). The mean
duration of each stage of the process leading to treatment,
as a percentage of the total time taken was as follows:
onset of symptoms to initial consultation, 45%; referral
and appointment with diagnostic specialist, 20%;
arrangement for diagnostic procedures, 14%; and
preparation for radiotherapy, 21%.
Staging investigations that were performed at the
time of diagnosis showed that 12 (7.1%) patients had
stage I NPC and 63 (37.5%) had stage II NPC. The
NPC in 75 (44.6%) patients had reached stage III
and that in 18 (10.7%) patients had reached stage IV.
All 127 patients with a duration of symptoms of less
than 6 months received a complete course of radical
radiotherapy; three (7.3%) of the 41 patients with
symptoms lasting 6 months or more, however, were
not treatable (two had advanced disease and died before
the commencement of radiotherapy and the third
patient defaulted).
Discussion
There is little dispute that the early detection and
treatment of NPC are important for increasing the
likelihood of cure for NPC patients. There is an urgent
need for review of the whole management pathway so
that different causes of delay can be identified and
appropriate improvements can be initiated. The present
detailed survey of consecutive patients referred for
primary treatment in public hospitals was hence
performed. Although the current study only covered a
3-month period, the data obtained gives useful infor-
mation for planning future action. The data are fairly
representative because all five clinical oncology depart-
ments in Hong Kong were included and because
there is little seasonal variation in referral pattern
(unpublished data). It should be noted, however, that
data on the onset of symptoms and initial consultations
depend on patients’ recall and the available medical
records. As it is impossible to scientifically verify their
accuracy, an in-depth statistical analysis has not been
attempted—this study is thus mainly descriptive.
There has been an encouraging reduction in the
interval between the onset of symptoms to the histo-
logical diagnosis of NPC in Hong Kong patients.10
Among patients who were treated between 1976 and
1985 at the Queen Elizabeth Hospital, the mean
symptom duration was 8 months and 50% of patients
had symptoms for 6 months or longer (classed as ‘late
presenters’).10 The corresponding duration in this study
has decreased to 5 months, and 24% of the patients
were late presenters. There is certainly no ground for
complacency, however: the proportion of patients with
advanced stage III-IV disease remained high (56%).
Further attempts for early detection are needed.
One of the most crucial steps for minimising the
delay in diagnosis and treatment is a greater, concerted
effort to improve public education. It took a mean
duration of 2.9 months from the onset of symptoms
for patients to seek medical advice (Table 2). Indeed,
patient delay attributed to 45% of the total time taken
from the appearance of the first symptom to the com-
mencement of radiotherapy. In addition, more than half
(54%) of the patients consulted various other doctors
before being referred to an appropriate specialist,
and this amounted to 20% of the total time lapse.
Hence, more active steps should be taken not only to
arouse public awareness about this leading cancer, but
also to disseminate information on the presenting
Table 4. Time taken by different clinical oncology departments
Centre Patients      Mean duration (range) [months]
Appointment* Preparation/waiting† Total
A 45 (27.8) 0.2 (0.0-0.6) 1.5 (0.7-3.3) 1.8 (0.9-3.4)
B 41 (25.3) 0.1 (0.0-0.4) 1.2 (0.5-2.8) 1.3 (0.6-2.9)
C 34 (21.0) 0.2 (0.0-0.6) 1.6 (0.7-2.1) 1.7 (0.8-2.2)
D 26 (16.0) 0.1 (0.0-0.2) 0.8 (0.5-1.8) 0.9 (0.5-1.9)
E 16 (9.9) 0.2 (0.0-0.4) 0.9 (0.5-1.6) 1.1 (0.6-1.7)
Total‡ 162 0.2 (0.0-0.6) 1.3 (0.5-3.3) 1.4 (0.5-3.4)
* Waiting time for first appointment with radiotherapist
†
 Interval from the date of first appointment to commencement of radiotherapy
‡
 Excluding three patients who initially refused treatment and another three who did not receive radiotherapy
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symptoms and the most direct channels of consultation
when related symptoms are noted.
It is most worrying that the two most common
complaints at presentation were associated with the
longest delays in diagnosis (Table 1). Approximately
42% of the patients had nasal symptom(s) and the
mean duration before attaining diagnosis was as
long as 6.1 months, because serious epistaxis was rare
and most patients only had vague postnasal drip. The
mean duration before presentation was 3.6 months;
patients had to wait a further 2.5 months before the
diagnosis was established. The public also failed to
recognise that persistent neck mass is a sinister sign;
on average, patients waited 2.7 months before going
to a doctor.
While most doctors had little problem in diagnosing
NPC in patients with cervical lymphadenopathy, the
association with otological symptoms remained
inadequately recognised: doctors required 1.2 and 2.7
months, respectively, to make a diagnosis (Table 1). The
continuous medical education of all front-line clinicians
is needed to ensure that this differential diagnosis will
not be inadvertently missed, thus minimising the time
required for its recognition.
Most (83.9%) patients were referred to specialists
in public institutions for histological confirmation.
Because of the introduction of a system that screens
referrals to prioritise appointments, the time taken was
not excessive: the total mean time taken (including
waiting time for first appointment, arranging biopsy,
and referral to a clinical oncology department) was
1.1 months. This is still relatively long compared with
the private sector, which could provide the service
within 0.2 months. Further streamlining of procedures
and more speedy arrangements for radiological and
pathological investigations in public hospitals are
required. In addition, close liaison should be
established between public institutions and the private
sector. The primary health care doctor must be well
informed not only about the referral procedures, but
also the indications and the arrangements for urgent
consultation. Indeed, patients with a high suspicion
of NPC could even be referred directly to clinical
oncology departments for histological confirmation
and simultaneous preparation for radiotherapy.
The mean total time taken by clinical oncology
departments to treat NPC patients amounted to 21%
of the total time lapse. This varied from 0.9 to 1.8
months among the different public centres, although
all centres managed to see the patient within 0.2
months from referral. A reduction in the waiting time
for treatment depends on the availability of linear
accelerators and planning facilities, as well as sup-
porting services (eg staging investigations and dental
preparation). Hence, a coordinated effort by all the
departments involved is needed to improve the
situation. A better cross-referral system to divert
patients from centres that have a long waiting list
would also help to reduce the waiting time for
radiotherapy.
The detrimental effects of delaying presentation on
the cancer stage and ultimate survival have been
described in a preceding study.10 Furthermore, the
psychological distress of waiting for a life-saving
treatment is substantial.11 Although the long-term
outcome cannot be assessed from this descriptive
survey, it was notable that 5% of patients who had
had symptoms for more than 6 months died before
radiotherapy could be started. The need for minimising
the time lapse before diagnosis and treatment is
important. The success of attempts at achieving this
depends not only on patients, but also all the health
care providers involved.
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